Delayed presentation of cytomegalovirus retinitis in an infant with severe congenital cytomegalovirus infection

Retina

Volumn 30, Issue 4 SUPPL. 4, 2010, Pages

  Coors, Lori E ^a   Spencer, Rand ^a  

^a TEXAS RETINA ASSOCIATES   (United States)

Author keywords

Chorioretinitis; Congenital CMV; Cytomegalovirus; Ganciclovir; Valganciclovir

Indexed keywords

GANCICLOVIR; VALGANCICLOVIR;

ANAMNESIS; CASE REPORT; CHORIORETINITIS; CLINICAL FEATURE; CONFERENCE PAPER; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; FOLLOW UP; HOSPITALIZATION; HUMAN; INFANT; MALE; RETINITIS;

CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS RETINITIS; HUMANS; INFANT; MALE; REMISSION, SPONTANEOUS;

EID: 77951093955     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181c7018d     Document Type: Conference Paper

References (18)

1. Kimberlin DW, Lin CY, Sanchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003;143:16-25.
2. Demmler GJ. Summary of workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991;13:315-329.
3. Kimberlin DW, Acosta EP, Sanchez PJ, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis 2008;197:836-845.
4. Stagno S, Pass RF, Dworsky ME, Alford CA. Congenital and perinatal CMV infections. Semin Perinatol 1983;7:31-42.
5. Istas AS, Demmler GJ, Dobbins JG, Stewart JA. The National Congenital CMV Disease Registry Collaborating Group. Survelliance for CMV disease: a report from the National Congenital CMV Disease Registry. Clin Infect Dis 1995;20:665-670.
6. Michaels MG, Greenberg DP, Sabo DL, Wald ER. Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr Infect Dis 2003;22:504-508.
7. Smets K, DeCoen K, Dhooge I, et al. Selecting neonates with congenital cytomegalovirus infection for ganciclovir therapy. Eur J Pediatr 2006;165:885-890.
8. Adler SP, Nigro G, Pereira L. Recent advances in the prevention and treatment of congenital cytomegalovirus infections. Semin Perinatol 2007;31:10-18.
9. Tanaka-Kitajima N, Sugaya N, Futatani T, et al. Ganciclovir therapy for congenital cytomegalovirus infection in six infants. Pediatr Infect Dis J 2005;24:782-785.
10. Barampouti F, Rajan M, Aclimandos W. Should active CMV retinitis in non-immunocompromised newborn babies be treated? Br J Ophthalmol 2002;86:248-249.
11. Baumal CR, Levin AV, Read SE. Cytomegalovirus retinitis in immunosuppressed children. Am J Ophthalmol 1999;127:550-558.
12. Bobbana S, Amos C, Britt W, Stagno S, Alford C, Pass R. Late onset and reactivation of chorioretinitis in children with congenital cytomegalovirus infection. Pediatr Infect Dis J 1994; 13:1139-1142.
13. Vaudaux JD, Holland GN. In: Stephen J. Ryan, ed. Retina. 4th ed. Philadelphia: Mosby; 2006:1633-1638.
14. Wutzler P, Thrust R. Genetic risks of antiviral nucleoside analogues-a survey. Antiviral Res 2001;49:55-74.
15. Faqi AS, Klug A, Merker HJ, Chahoud I. Ganciclovir induces reproductive hazards in male rats after short-term exposure. Hum Exp Toxicol 1997;16:505-511.
16. Meine Jansen CF, Toet MC, Rademaker CM, Ververs TF, Gerards LJ, van Loon AM. Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir. J Perinat Med 2005;33:364-366.
17. Galli L, Novelli A, Chiappini E, et al. Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants. Pediatr Infect Dis J 2007;26: 451-453.
18. Richard J. Whitley; National Institute of Allergy and Infectious Diseases (NIAID). Phase III, randomized, placebo-controlled, blinded investigation of six weeks vs six months of oral valganciclovir therapy in infants with symptomatic congenital cytomegalovirus infection (CASG 112). DMID Protocol Number: 06-0046; NCT00466817. Bethesda, MD: National Institute of Allergy and Infectious Diseases.